DDT vs PATH
Dillards Capital Trust I (DDT) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Dillards Capital Trust I (DDT) common stock listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported DDT revenue for 2025-02-01 was $6.48B. Net income was $593.5M. Revenue was down 4.0% from 2024-02-03 to 2025-02-01. DDT currently screens at market cap $0.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
DDT currently screens at market cap $0. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the DDT and PATH stock pages for the full models.
Not investment advice.